BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27128689)

  • 41. TDP2 protects transcription from abortive topoisomerase activity and is required for normal neural function.
    Gómez-Herreros F; Schuurs-Hoeijmakers JH; McCormack M; Greally MT; Rulten S; Romero-Granados R; Counihan TJ; Chaila E; Conroy J; Ennis S; Delanty N; Cortés-Ledesma F; de Brouwer AP; Cavalleri GL; El-Khamisy SF; de Vries BB; Caldecott KW
    Nat Genet; 2014 May; 46(5):516-21. PubMed ID: 24658003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanism of repair of 5'-topoisomerase II-DNA adducts by mammalian tyrosyl-DNA phosphodiesterase 2.
    Schellenberg MJ; Appel CD; Adhikari S; Robertson PD; Ramsden DA; Williams RS
    Nat Struct Mol Biol; 2012 Dec; 19(12):1363-71. PubMed ID: 23104055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 4-Benzylideneisoquinoline-1,3(
    Senaweera S; He T; Cui H; Aihara H; Wang Z
    Med Chem Res; 2021 Feb; 30(2):371-386. PubMed ID: 33776385
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ubiquitin stimulated reversal of topoisomerase 2 DNA-protein crosslinks by TDP2.
    Schellenberg MJ; Appel CD; Riccio AA; Butler LR; Krahn JM; Liebermann JA; Cortés-Ledesma F; Williams RS
    Nucleic Acids Res; 2020 Jun; 48(11):6310-6325. PubMed ID: 32356875
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mammalian Tyrosyl-DNA Phosphodiesterases in the Context of Mitochondrial DNA Repair.
    Huang SN; Pommier Y
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31226795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inactivating TDP2 missense mutation in siblings with congenital abnormalities reminiscent of fanconi anemia.
    Zagnoli-Vieira G; Brazina J; Van Den Bogaert K; Huybrechts W; Molenaers G; Caldecott KW; Van Esch H
    Hum Genet; 2023 Sep; 142(9):1417-1427. PubMed ID: 37558815
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biochemical assays for the discovery of TDP1 inhibitors.
    Marchand C; Huang SY; Dexheimer TS; Lea WA; Mott BT; Chergui A; Naumova A; Stephen AG; Rosenthal AS; Rai G; Murai J; Gao R; Maloney DJ; Jadhav A; Jorgensen WL; Simeonov A; Pommier Y
    Mol Cancer Ther; 2014 Aug; 13(8):2116-26. PubMed ID: 25024006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TDP2 suppresses chromosomal translocations induced by DNA topoisomerase II during gene transcription.
    Gómez-Herreros F; Zagnoli-Vieira G; Ntai I; Martínez-Macías MI; Anderson RM; Herrero-Ruíz A; Caldecott KW
    Nat Commun; 2017 Aug; 8(1):233. PubMed ID: 28794467
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pleiotropic functions of EAPII/TTRAP/TDP2: cancer development, chemoresistance and beyond.
    Li C; Sun SY; Khuri FR; Li R
    Cell Cycle; 2011 Oct; 10(19):3274-83. PubMed ID: 21926483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ZATT (ZNF451)-mediated resolution of topoisomerase 2 DNA-protein cross-links.
    Schellenberg MJ; Lieberman JA; Herrero-Ruiz A; Butler LR; Williams JG; Muñoz-Cabello AM; Mueller GA; London RE; Cortés-Ledesma F; Williams RS
    Science; 2017 Sep; 357(6358):1412-1416. PubMed ID: 28912134
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties.
    Khomenko T; Zakharenko A; Odarchenko T; Arabshahi HJ; Sannikova V; Zakharova O; Korchagina D; Reynisson J; Volcho K; Salakhutdinov N; Lavrik O
    Bioorg Med Chem; 2016 Nov; 24(21):5573-5581. PubMed ID: 27658793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TDP2 suppresses genomic instability induced by androgens in the epithelial cells of prostate glands.
    Al Mahmud MR; Ishii K; Bernal-Lozano C; Delgado-Sainz I; Toi M; Akamatsu S; Fukumoto M; Watanabe M; Takeda S; Cortés-Ledesma F; Sasanuma H
    Genes Cells; 2020 Jul; 25(7):450-465. PubMed ID: 32277721
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mutant p53 cooperates with ETS2 to promote etoposide resistance.
    Do PM; Varanasi L; Fan S; Li C; Kubacka I; Newman V; Chauhan K; Daniels SR; Boccetta M; Garrett MR; Li R; Martinez LA
    Genes Dev; 2012 Apr; 26(8):830-45. PubMed ID: 22508727
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gold nanoparticles - an optical biosensor for RNA quantification for cancer and neurologic disorders diagnosis.
    Shawky SM; Awad AM; Abugable AA; El-Khamisy SF
    Int J Nanomedicine; 2018; 13():8137-8151. PubMed ID: 30555231
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tyrosyl-DNA Phosphodiesterase 1 Inhibitors: Usnic Acid Enamines Enhance the Cytotoxic Effect of Camptothecin.
    Zakharenko A; Luzina O; Koval O; Nilov D; Gushchina I; Dyrkheeva N; Švedas V; Salakhutdinov N; Lavrik O
    J Nat Prod; 2016 Nov; 79(11):2961-2967. PubMed ID: 27933897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DNA and RNA Cleavage Complexes and Repair Pathway for TOP3B RNA- and DNA-Protein Crosslinks.
    Saha S; Sun Y; Huang SN; Baechler SA; Pongor LS; Agama K; Jo U; Zhang H; Tse-Dinh YC; Pommier Y
    Cell Rep; 2020 Dec; 33(13):108569. PubMed ID: 33378676
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibitory Effect of New Semisynthetic Usnic Acid Derivatives on Human Tyrosyl-DNA Phosphodiesterase 1.
    Dyrkheeva N; Luzina O; Filimonov A; Zakharova O; Ilina E; Zakharenko A; Kuprushkin M; Nilov D; Gushchina I; Švedas V; Salakhutdinov N; Lavrik O
    Planta Med; 2019 Jan; 85(2):103-111. PubMed ID: 30142660
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel Semisynthetic Derivatives of Bile Acids as Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibitors.
    Salomatina OV; Popadyuk II; Zakharenko AL; Zakharova OD; Fadeev DS; Komarova NI; Reynisson J; Arabshahi HJ; Chand R; Volcho KP; Salakhutdinov NF; Lavrik OI
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29562592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New Hydrazinothiazole Derivatives of Usnic Acid as Potent Tdp1 Inhibitors.
    Filimonov AS; Chepanova AA; Luzina OA; Zakharenko AL; Zakharova OD; Ilina ES; Dyrkheeva NS; Kuprushkin MS; Kolotaev AV; Khachatryan DS; Patel J; Leung IKH; Chand R; Ayine-Tora DM; Reynisson J; Volcho KP; Salakhutdinov NF; Lavrik OI
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31619021
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of magnesium requirement of human 5'-tyrosyl DNA phosphodiesterase mediated reaction.
    Adhikari S; Karmahapatra SK; Karve TM; Bandyopadhyay S; Woodrick J; Manthena PV; Glasgow E; Byers S; Saha T; Uren A
    BMC Res Notes; 2012 Mar; 5():134. PubMed ID: 22405347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.